Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Gram-negative bacterial outer membrane is a complex structure crucial for protection against environmental threats, maintenance of cellular integrity under stress conditions, mediation of host-pathogen interactions via surface molecules like LPS and OMPs, and conferring significant resistance to many antibiotics through its selective permeability barrier function. Its unique composition—particularly LPS—and biogenesis mechanisms make it both a challenge for clinical treatment strategies and an attractive target for novel antimicrobial development.
Various mechanisms, including disruption of membrane integrity (e.g., polymyxins), inhibition of OMP assembly, or LPS neutralization.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gram-negative Bacterial Outer Membrane (OM).